Hayakawa Mikito
Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center.
Rinsho Shinkeigaku. 2013;53(11):951-5. doi: 10.5692/clinicalneurol.53.951.
Neuroendovascular therapy is a rapidly evolving clinical subspecialty because of its minimal invasiveness and novel device development. In Japan, neurosurgeons perform a substantial portion of neuroendovascular procedures, however, the number of neurologists who certified by the Japanese Society for Neuroendovascular Therapy (interventional neurologist) is gradually increasing. Neurologists tend to deal with medical treatment in the acute stage and prevention of ischemic stroke, in addition, neuroendovascular procedures for ischemic cerebrovascular diseases performed by neurologists themselves, such as acute revascularization therapy for acute intracranial major artery occlusion or carotid artery stenting, might provide various benefits to ischemic stroke patients because of the smooth, seamless and close management from admission, to intervention, to discharge and after discharge. Because of insufficient number of interventionists to perform emergent neurointerventional procedures in the clinical setting of acute ischemic stroke in Japan, we wish that more neurologists get interested in and receive training in the neuroendovascular therapy.
神经血管内治疗是一个快速发展的临床亚专业,这得益于其微创性和新型设备的开发。在日本,神经外科医生进行了相当一部分神经血管内手术,然而,通过日本神经血管内治疗学会认证的神经科医生(介入神经科医生)数量正在逐渐增加。神经科医生倾向于处理急性期的医疗治疗和缺血性中风的预防,此外,神经科医生自己进行的缺血性脑血管疾病的神经血管内手术,如急性颅内主要动脉闭塞的急性血管再通治疗或颈动脉支架置入术,可能会因为从入院到干预、再到出院及出院后的顺利、无缝且密切的管理,为缺血性中风患者带来各种益处。由于在日本急性缺血性中风临床环境中进行紧急神经介入手术的介入医生数量不足,我们希望有更多的神经科医生对神经血管内治疗感兴趣并接受相关培训。